Method for treating a steroid resistant condition via administra

Drug – bio-affecting and body treating compositions – Lymphokine – Interferon

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530351, A61K 3700, A61K 3766

Patent

active

052663124

ABSTRACT:
The invention relates to a method for a steroid resistant condition via administration of gamma interferon to a subject, such as a human, afflicted with the condition. The gamma interferon is administered in an amount sufficient to alleviate at least one parameter associated with the steroid resistant condition.

REFERENCES:
patent: 4944941 (1990-07-01), Ammarn
Kamada, A. K. et al. "Steroid Resistance in Asthma: our current understanding" Pediatric Pulmonology, 00:000-000 (1992) pp. 1-7.
Boguniewicz et al., "Recombinant Gamma Interferon Treatment of Pat. with Atopic Dermatitis," Am. J. Medicine:vol. 88 pp. 365-370 (1990).
Adinoff and Clark, "The Allergic Nature of Atopic Dermatitis", Immunology and Allergy Practice, May, pp. 191/17-28/202 (1989).
Sampson, H. A., "Role of Immediate Hypersensitivity in the Pathogenesis of Atopic Dermatitis", Allergy, vol. 44, Suppl. 9, pp. 52-58 (1989).
Ezekowitz et al., "Partial Correction of the Phagocyte Defect . . . by Subcutaneous Interferon Gamma", NEJM, 319:146-151 (Jul. 21), 1988.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method for treating a steroid resistant condition via administra does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for treating a steroid resistant condition via administra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating a steroid resistant condition via administra will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2093757

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.